William Aliski, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 8,500 shares at $149.01 ($1.1M) on 2021-02-19, disclosed to the SEC on 2021-02-23.
Open-market sale of $1.1M RARE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.01 | 7,500 | $1.1M | 100.0% |
| 2 | $0.00 | 1,000 | $0 | 0.0% |
| Total | $131.48 avg | 8,500 | $1.1M | 100% |
| Filing → |
| RARE | SELL | 2020-05-20 | $560K | — | Filing → |
| AGTC | BUY | 2018-12-18 | $19K | — | Filing → |
| RARE | SELL | 2018-12-07 | $298K | — | Filing → |